The Stent with Exceptional Flexibility and Ultra-Thin Strut Thickness (65 µm)
Unique stent design together with proven efficacy of Sirolimus drug & Biodegradable polymers resulted into Trackflex with excellent safety & efficacy profile
Sirolimus Drug being more lipophilic than other limus family drug, penetrates rapidly at the target lesion and provides rapid cell inhibitory action. Sirolimus stents are well proven to show less restenosis, stent thrombosis and perprocedural myocardial infraction compared to earlier generation of Drug Eluting Stents.
< 5%
Recoil
Nearly Zero
Foreshortening
1.6 mm
Radial Strength
Trackflex
Sirolimus Eluting Coronary Stent System
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
- Established Sirolimus Efficacy
- Best-in-Class Deliverability
- Excellent Side Branch Access
- Proven blend of Sirolimus & Biodegradable Polymers
Stent Design Features
- The stent design is uniform having sequential rings throughout the length of the stent, without any design difference at top/bottom of the stent.
- Cells are arranged uniformly in a single row and the same pattern is followed throughout the stent length.
- Struts shows a wavy pattern and are not straight.
- “Elongated N” connectors provides MID struts connections. The “Elongated N” connectors originates from the MID of the struts in the previous row and ends in the mid of the struts in the subsequent row.
- “Elongated N” Connectors are placed alternatively in intra and inter rows throughout the stent length.
Drug Release Profile
Trackflex has proven drug release kinetics. Initial burst of Sirolimus followed by sustained release up to 30 Days. Biodegradable polymers completely degrades by hydrolysis & enzymatic degradation which is eventually exreted from body in form of CO2 and H2O.
What Makes Trackflex As an Extra Ordinary Cardiac Stent?
Trackflex is the epitome of quality and performance. It offers, excellent flexibility, versatile clinical performance, reduces artery injuries, outstanding Sirolimus drug coating characteristics which deliver the drug in the controlled fashion at the target site, and ultra-thin stent thickness (65 um).
Cobalt Chromium Stent Platform
Meticulously laser cut Cobalt Chromium Stent proves to be an ideal platform for DES, contributing to high flexibility, conformability, unidirectional expansion with no edge flaring and minimum recoil.
Polymers
Meticulously laser cut Cobalt Chromium Stent proves to be an ideal platform for DES, contributing to high flexibility, conformability, unidirectional expansion with no edge flaring and minimum recoil.
Sirolimus Drug
The cytostatic drug, inhibits blood vessel restenosis by limiting the proliferation of smooth muscle cells
PTCA Balloon Catheter
Drug coated stent is mounted on the balloon portion of PTCA Balloon Catheter, the latter assists in stent positioning & dilatation. The Ultra-low profile, excellent cross ability and flexible tip of PTCA balloon Catheter help entire stent system to achieve its expected clinical outcomes.
Stent Specification
Design: Open Cell Stent Design
Material: Cobalt Chromium (CoCr) L605
Length (mm): 8, 13, 16, 20, 24, 28, 32, 36, 40, 43, & 47
Diameter (mm): 2.00, 2.25, 2.50, 2.75, 3.00,
3.50, 4.00 & 4.50
Strut Dimensions: Thickness 65 um | Strut 70 um | Connectors 50 um
Nominal Pressure (NP): 9 atm
Recoil:5%
Crossing Profile: Nearly 1.00 mm
Min. Guidewire Diameter: 0.014”
Min. Guiding Catheter I.D.: 5 Fr Compatible
Radial Strength: Excellent
Flexibility: Excellent
Rated Burst Pressure (RBP): 16 atm
Foreshortening: Nearly Zero
Ordering Information
| Stent Length (mm) | |||||||||||
| Diameter (mm) | 8 | 13 | 16 | 20 | 24 | 28 | 32 | 36 | 40 | 43 | 47 |
| 2.00 | TF20008 | TF20013 | TF20016 | TF20020 | TF20024 | TF20028 | TF20032 | TF20036 | TF20040 | TF20043 | TF20047 |
| 2.25 | TF22508 | TF22513 | TF22516 | TF22520 | TF22524 | TF22528 | TF22532 | TF22536 | TF22540 | TF22543 | TF22547 |
| 2.50 | TF25008 | TF25013 | TF25016 | TF25020 | TF25024 | TF25028 | TF25032 | TF25036 | TF25040 | TF25043 | TF25047 |
| 2.75 | TF27508 | TF27513 | TF27516 | TF27520 | TF27524 | TF27528 | TF27532 | TF27536 | TF27540 | TF27543 | TF27547 |
| 3.00 | TF30008 | TF30013 | TF30016 | TF30020 | TF30024 | TF30028 | TF30032 | TF30036 | TF30040 | TF30043 | TF30047 |
| 3.50 | TF35008 | TF35013 | TF35016 | TF35020 | TF35024 | TF35028 | TF35032 | TF35036 | TF35040 | TF35043 | TF35047 |
| 4.00 | TF40008 | TF40013 | TF40016 | TF40020 | TF40024 | TF40028 | TF40032 | TF40036 | TF40040 | TF40043 | TF40047 |
| 4.50 | TF45008 | TF45013 | TF45016 | TF45020 | TF45024 | TF45028 | TF45032 | TF45036 | TF45040 | TF45043 | TF45047 |
NEWS & MEDIA
© 2020 Kamal Medtech. All Rights Reserved. Please read the Legal Notice for further details. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Kamal Medtech, its subsidiaries or affiliates. No use of any Kamal Medtech trademark, trade name, or trade dress in this site may be made without the prior written authorization of Kamal Medtech, except to identify the product or services of the company.